Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/811,311, filed Feb 27, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,471,676 | Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays In force · High confidence UsedRemaining | Novocure GmbH | In force | High confidence | ||
| US 11,607,543 | Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays In force · High confidence | Novocure GmbH | In force | High confidence | ||
| US 11,857,782 | Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays In force · High confidence | Novocure GmbH | In force | High confidence | ||
| US 12,285,605 | Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays In force · High confidence | Novocure GmbH | In force | High confidence | ||
| Application 19/093,702 | Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays Pending Not granted | Novocure GmbH | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Novocure GmbH.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.